IGHv mutations for Chronic Lymphocytic Leukemia (CLL)
CIDEGEN
Delivery time
1-2 weeks
Sample
Blood
166,98€
Analysis of IGHv gene mutational status in CLL. The IGHv gene mutational status is a key prognostic marker in CLL. Mutations in IGHv are associated with slower disease progression and a better response to treatment.
Other tests
Trisomy 11 (Blood. Biopsy tissue)
166,98€
Trisomy 11 (Blood. Biopsy tissue. Bone marrow)
166,98€
Sequencing of exons 9, 11, 13 and 14 of the POLE gene. (Analysis in biopsy tissue)
932,31€